HEALTH and PHARMA NEWS

Influenza A Virus, H3N2 Subtype Infections Drug Market Outlook to 2025 - Leading Key Manufacturers AbbVie, Aphios Corporation, Celltrion, FluGen, ILiAD Biotechnologies, LLC, Inovio Pharmaceuticals, Johnson & Johnson, Medicago Inc.

Pressmeddelande   •   Jun 12, 2019 13:12 CEST

The global Influenza A Virus, H3N2 Subtype Infections Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza A Virus, H3N2 Subtype Infections Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Have any query about this report, ask our expert @ http://www.qyresearchmedical.com/submit-inquiry/4372

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

AbbVie Inc

AIMM Therapeutics B.V.

Aphios Corporation

Celltrion, Inc.

FluGen, Inc.

Glide Pharmaceutical Technologies Limited

ILiAD Biotechnologies, LLC

Inovio Pharmaceuticals, Inc.

Johnson & Johnson

Medicago Inc.

MedImmune, LLC

Mucosis B.V.

NanoViricides, Inc.

OPKO Health, Inc.

Sarepta Therapeutics, Inc.

VBI Vaccines Inc.

Visterra, Inc.

Zydus Cadila Healthcare Limited

Segment by Regions

North America

Europe

China

Japan

Segment by Type

NEO-8877

NP-025

NSC-61610

NVINF-1

Others

Segment by Application

Clinic

Hospital

Others

TABLE OF CONTENT

Table of Contents

Executive Summary

1 Influenza A Virus, H3N2 Subtype Infections Drug Market Overview

1.1 Product Overview and Scope of Influenza A Virus, H3N2 Subtype Infections Drug

1.2 Influenza A Virus, H3N2 Subtype Infections Drug Segment by Type

1.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Comparison by Type (2014-2025)

1.2.2 NEO-8877

1.2.3 NP-025

1.2.4 NSC-61610

1.2.5 NVINF-1

1.2.6 Others

1.3 Influenza A Virus, H3N2 Subtype Infections Drug Segment by Application

1.3.1 Influenza A Virus, H3N2 Subtype Infections Drug Consumption Comparison by Application (2014-2025)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market by Region

1.3.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Region

1.3.2 North America Status and Prospect (2014-2025)

1.3.3 Europe Status and Prospect (2014-2025)

1.3.4 China Status and Prospect (2014-2025)

1.3.5 Japan Status and Prospect (2014-2025)

1.3.6 Southeast Asia Status and Prospect (2014-2025)

1.3.7 India Status and Prospect (2014-2025)

1.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size

1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2014-2025)

1.4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2025)

2 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Competition by Manufacturers

2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Manufacturers (2014-2019)

2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers (2014-2019)

2.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Average Price by Manufacturers (2014-2019)

2.4 Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Production Sites, Area Served, Product Types

2.5 Influenza A Virus, H3N2 Subtype Infections Drug Market Competitive Situation and Trends

2.5.1 Influenza A Virus, H3N2 Subtype Infections Drug Market Concentration Rate

2.5.2 Influenza A Virus, H3N2 Subtype Infections Drug Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Regions

3.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Regions

3.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Regions (2014-2019)

3.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

3.4 North America Influenza A Virus, H3N2 Subtype Infections Drug Production

3.4.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)

3.4.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

3.5 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production

3.5.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)

3.5.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

3.6 China Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2019)

3.6.1 China Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)

3.6.2 China Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

3.7 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2019)

3.7.1 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)

3.7.2 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Regions

4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Regions

4.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)

4.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)

4.4 China Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)

4.5 Japan Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)

5 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price Trend by Type

5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Type (2014-2019)

5.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Type (2014-2019)

5.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2014-2019)

5.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth by Type (2014-2019)

6 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis by Applications

6.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Market Share by Application (2014-2019)

6.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Influenza A Virus, H3N2 Subtype Infections Drug Business

7.1 AbbVie Inc

7.1.1 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.1.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.1.3 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.1.4 Main Business and Markets Served

7.2 AIMM Therapeutics B.V.

7.2.1 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.2.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.2.3 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.2.4 Main Business and Markets Served

7.3 Aphios Corporation

7.3.1 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.3.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.3.3 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.3.4 Main Business and Markets Served

7.4 Celltrion, Inc.

7.4.1 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.4.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.4.3 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.4.4 Main Business and Markets Served

7.5 FluGen, Inc.

7.5.1 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.5.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.5.3 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.5.4 Main Business and Markets Served

7.6 Glide Pharmaceutical Technologies Limited

7.6.1 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.6.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.6.3 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.6.4 Main Business and Markets Served

7.7 ILiAD Biotechnologies, LLC

7.7.1 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.7.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.7.3 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.7.4 Main Business and Markets Served

7.8 Inovio Pharmaceuticals, Inc.

7.8.1 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.8.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.8.3 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.8.4 Main Business and Markets Served

7.9 Johnson & Johnson

7.9.1 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.9.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.9.3 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.9.4 Main Business and Markets Served

7.10 Medicago Inc.

7.10.1 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served

7.10.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification

7.10.3 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

7.10.4 Main Business and Markets Served

7.11 MedImmune, LLC

7.12 Mucosis B.V.

7.13 NanoViricides, Inc.

7.14 OPKO Health, Inc.

7.15 Sarepta Therapeutics, Inc.

7.16 VBI Vaccines Inc.

7.17 Visterra, Inc.

7.18 Zydus Cadila Healthcare Limited

8 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Cost Analysis

8.1 Influenza A Virus, H3N2 Subtype Infections Drug Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Influenza A Virus, H3N2 Subtype Infections Drug

8.4 Influenza A Virus, H3N2 Subtype Infections Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.2 Influenza A Virus, H3N2 Subtype Infections Drug Distributors List

9.3 Influenza A Virus, H3N2 Subtype Infections Drug Customers

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities

10.3 Market Drivers

10.4 Challenges

10.5 Influence Factors

11 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Forecast

11.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast

11.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast (2019-2025)

11.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate Forecast (2019-2025)

11.1.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price and Trend Forecast (2019-2025)

11.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Forecast by Regions (2019-2025)

11.2.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)

11.2.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)

11.2.3 China Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)

11.2.4 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)

11.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast by Regions (2019-2025)

11.3.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)

11.3.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)

11.3.3 China Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)

11.3.4 Japan Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)

11.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue and Price Forecast by Type (2019-2025)

11.5 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Author List

13.4 Disclaimer

Buy now this market study - http://www.qyresearchmedical.com/report/checkout/4372/2900

PDF File Dispatch Time - 24 Hours. We Will also support Word, PPT, Excel Files Dispatch

Contact Us:

QYResdearch Medical

URL - http://www.qyresearchmedical.com/

Mailing Address : Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Any Assistance, Email – sales@qyresearchmedical.com